MiMedx Group, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
MiMedx Group, Inc. (MDXG) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $9.63 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-02-25
- MiMedx Group, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2023-03-31 was $5.44.
- MiMedx Group, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2022-03-31 was $0.00.
- MiMedx Group, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2021-03-31 was $0.00.
- MiMedx Group, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2017-03-31 was $5.80, a 8.52% decline year-over-year.
- MiMedx Group, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2025 was $9.63, a 34.31% increase from fiscal 2024.
- MiMedx Group, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2024 was $7.17, a 22.56% increase from fiscal 2023.
- MiMedx Group, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2023 was $5.85, a 45.52% increase from fiscal 2022.
- MiMedx Group, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2022 was $4.02, a 226.83% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2025-12-31 | $9.63 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $7.17 10-K · filed 2025-02-26 | |||
| 2023-12-31 | $5.85 10-K · filed 2024-02-28 | |||
| 2023-09-30 | $5.81 10-Q · filed 2023-10-30 | |||
| 2023-06-30 | $5.73 10-Q · filed 2023-08-01 | |||
| 2023-03-31 | $5.44 10-Q · filed 2023-05-02 | |||
| 2022-12-31 | $4.02 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $4.00 10-Q · filed 2022-11-02 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-02 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-03 | |||
| 2021-12-31 | $1.23 10-K · filed 2022-02-28 | |||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-02 | |||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-03 | |||
| 2021-03-31 | $0.00 10-Q · filed 2021-04-28 | |||
| 2020-12-31 | $5.90 10-K · filed 2021-03-08 | |||
| 2019-12-31 | $6.21 10-K · filed 2020-07-06 | |||
| 2018-12-31 | $2.22 10-K · filed 2020-03-17 | |||
| 2017-09-30 | $5.79 10-Q · filed 2017-10-31 | |||
| 2017-06-30 | $5.71 10-Q · filed 2017-07-31 | |||
| 2017-03-31 | $5.80 10-Q · filed 2017-05-01 | |||
| 2016-12-31 | $6.16 10-K · filed 2017-03-01 | |||
| 2016-09-30 | $6.77 10-Q · filed 2016-11-08 | |||
| 2016-06-30 | $6.44 10-Q · filed 2016-08-02 | |||
| 2016-03-31 | $6.34 10-Q · filed 2016-05-10 | |||
| 2015-12-31 | $2.61 10-K · filed 2017-02-22 | |||
| 2015-09-30 | $1.89 10-Q · filed 2015-11-06 | |||
| 2015-06-30 | $7.00 10-Q · filed 2015-08-07 | |||
| 2014-12-31 | $0.81 10-K · filed 2015-03-13 | |||
| 2014-09-30 | $0.81 10-Q · filed 2014-11-10 | |||
| 2014-06-30 | $1.28 10-Q · filed 2014-08-11 | |||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | |||
| 2013-12-31 | $1.11 10-K · filed 2014-03-04 | |||
| 2013-09-30 | $1.11 10-Q · filed 2013-11-08 | |||
| 2013-06-30 | $1.11 10-Q · filed 2013-08-08 | |||
| 2013-03-31 | $1.15 10-Q · filed 2013-05-10 | |||
| 2012-12-31 | $1.55 10-K · filed 2013-03-15 | |||
| 2011-12-31 | $1.70 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |